查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1876774

2032年居家机器人辅助復健市场预测：按类型、治疗类型、最终用户和地区分類的全球分析

Home-Based Robot Assisted Rehabilitation Market Forecasts to 2032 - Global Analysis By Type (Robot Type, Sensor Type, and Deployment Mode), Therapy Type, End User, and By Geography.
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的研究，预计到 2025 年，全球家庭机器人辅助復健市场规模将达到 4.281 亿美元，到 2032 年将达到 11.524 亿美元，预测期内复合年增长率为 15.2%。

居家机器人辅助復健利用家庭环境中的机器人设备，辅助中风、创伤和神经系统疾病患者的物理治疗。这些系统提供指导性锻炼、即时回馈和自适应阻力，从而实现个人化復健方案。它们与远端医疗平台集成，便于临床医生进行远端监测，并提高患者的依从性。这项技术减少了就诊次数，降低了成本，并提高了老年人的康復便利性。目前，居家机器人辅助復健正越来越多地应用于术后护理和慢性病管理，填补了传统復健服务的空白。

约翰霍普金斯大学的一项研究发现，中风后使用配备感测器的机器人辅助进行上肢復健治疗的患者，与接受标准家庭运动计画的患者相比，在任务准确性和一致性方面提高了 30%。

老化和中风后人群

全球人口老化和中风相关残疾发生率的上升，推动了居家机器人辅助復健的需求。这些系统提供个人化治疗，改善行动能力，并减少对医院就诊的依赖。随着人口老化和慢性病的盛行率增加，机器人復健为长期照护提供了一种扩充性且经济高效的解决方案。各国政府和医疗机构正在投资辅助技术，以支持独立生活并减轻医院的负担。这种人口结构变化是市场扩张的主要驱动力。

较高的初始实施和维修成本

儘管机器人復健系统具有许多临床益处，但其高昂的前期成本限制了其广泛应用。这些成本包括硬体、软体整合、培训和持续维护。这些费用通常不在保险范围内，使得许多家庭难以负担。此外，技术复杂性和定期维护的需求也增加了营运负担。在建立经济高效的模式和报销机制之前，市场渗透率将持续受限，尤其是在低收入和农村地区。

与远端医疗復健计划的整合

将机器人復健系统与远端医疗平台结合，蕴藏着巨大的发展机会。远端监测、虚拟治疗和人工智慧驱动的进度追踪，显着提升了医疗服务的可及性和连续性。患者足不出户即可获得临床医师的指导和回馈。这种混合模式有助于术后復健、慢性病管理和中风復健。随着远端医疗的普及，机器人技术与数位医疗基础设施的整合将催生新的服务模式，并将服务范围扩展到医疗资源匮乏的地区。

机器人疗法的监管障碍

机器人復健系统面临复杂的监管路径，尤其是在家庭使用方面。核准流程因地区而异，通常需要大量的临床检验。安全性、有效性和资料隐私标准必须满足，这会延缓市场准入并增加合规成本。此外，远距復健和机器人介入缺乏统一的指导方针，也为製造商带来了不确定性。这些监管挑战会减缓创新，限制跨国扩充性，并对快速商业化构成威胁。

新冠疫情的影响：

新冠疫情加速了对远距復健解决方案的需求，包括居家机器人系统。封锁措施和医疗资源紧张凸显了分散式医疗服务的必要性。中风或手术后的患者可以在家中接受机器人治疗，从而降低感染风险。疫情危机刺激了对远端医疗和数位化治疗的投资，为机器人復健创造了有利环境。疫情结束后，结合线上线下治疗的混合式医疗模式日益普及，再次印证了居家机器人解决方案的长期重要性。

预计在预测期内，机器人类型细分市场将占据最大份额。

由于其多功能性和治疗精准性，机器人类復健系统预计将主导市场。这些系统包括外骨骼、末端执行器机器人和穿戴式设备，专为上肢和下肢復健而设计。它们能够提供重复的、特定任务的运动，从而促进运动功能恢復并提高患者参与治疗的动机。随着科技的进步，机器人正变得更加小巧、易于使用且价格更实惠。经临床检验的有效性和不断提高的患者接受度进一步巩固了该领域在家庭復健领域的主导地位。

预计在预测期内，运动復健领域将实现最高的复合年增长率。

受中风后和整形外科復健需求不断增长的推动，运动功能恢復领域预计将实现最高的复合年增长率。机器人系统提供针对性的训练，可增强肌肉力量、协调性和神经可塑性。人工智慧演算法可根据患者的復健进展制定个人化治疗方案，进而改善治疗效果。人们日益认识到早期疗育的重要性，这推动了运动功能恢復工具在急性和慢性疾病中的应用。该领域的扩充性和可衡量的影响是机器人復健的关键驱动因素。

占比最大的地区：

由于人口老化、中风发病率上升以及医疗基础设施不断完善，亚太地区预计将在预测期内占据最大的市场份额。中国、日本和韩国等国家正在投资辅助科技和居家照护模式。政府为促进数位医疗和復健服务而采取的措施进一步推动了这些技术的普及。当地製造商和Start-Ups公司正在开发符合当地需求的、经济高效的机器人解决方案。该地区的人口结构和政策环境使其成为机器人復健领域的领导者。

预计复合年增长率最高的地区：

在预测期内，北美预计将实现最高的复合年增长率，这主要得益于其先进的医疗保健生态系统、强大的研发能力以及对机器人疗法的早期应用。在美国和加拿大，家庭復健正在整合到远端医疗平台中，并得到了有利的报销政策的支持。主要企业和学术机构正在推动人工智慧机器人技术的创新。人们对中风后復健和慢性病管理的日益重视正在推动市场需求。监管支持和创业投资投资进一步促进了全部区域的市场成长。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，提供主要国家的市场估算和预测以及复合年增长率（註：可行性需确认）。
  • 竞争基准化分析
    • 根据主要企业的产品系列、地理覆盖范围和策略联盟基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 原始研究资料
    • 次级研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球家用机器人辅助復健市场（按类型划分）

  • 介绍
  • 机器人类型
    • 外骨骼机器人
    • 末端执行器机器人
    • 穿戴式机器人
    • 治疗陪伴机器人
  • 感测器类型
    • 动作感测器
    • 压力感测器
    • 肌电感测器
    • 温度和生物回馈疗法感测器
  • 部署模式
    • 独立式住宅单元
    • 云端连线系统
    • 行动应用整合装置

6. 全球家庭机器人辅助復健市场（依治疗类型划分）

  • 介绍
  • 运动功能恢復
  • 认知復健
  • 中风后治疗
  • 整形外科復健

7. 全球家用机器人辅助復健市场（依最终用户划分）

  • 介绍
  • 老年患者
  • 术后患者
  • 神经系统疾病患者

8. 全球家用机器人辅助復健市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第九章：重大发展

  • 协议、伙伴关係、合作和合资企业
  • 收购与併购
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十章：企业概况

  • Hocoma AG
  • ReWalk Robotics
  • Ekso Bionics
  • Myomo Inc.
  • Motus Nova
  • Tyromotion
  • Ottobock
  • Cyberdyne Inc.
  • Bionik Laboratories
  • Parker Hannifin
  • AlterG Inc.
  • Fourier Intelligence
  • Kinova
  • Rehab-Robotics Co.
  • MediTouch Ltd.
  • Hyundai Motor Company
  • SuitX
  • Palladyne AI
Product Code: SMRC32361

According to Stratistics MRC, the Global Home-Based Robot Assisted Rehabilitation Market is accounted for $428.1 million in 2025 and is expected to reach $1152.4 million by 2032 growing at a CAGR of 15.2% during the forecast period. Home-Based Robot Assisted Rehabilitation involves using robotic devices in domestic settings to support physical therapy for stroke, injury, or neurological conditions. These systems offer guided exercises, real-time feedback, and adaptive resistance, enabling personalized recovery programs. Integrated with telehealth platforms, they allow remote monitoring by clinicians and improve patient adherence. The technology reduces hospital visits, lowers costs, and enhances accessibility for aging populations. It's increasingly adopted in post-operative care and chronic condition management, bridging gaps in traditional rehabilitation services.

According to a Johns Hopkins University study, patients using sensor-equipped robotic guides for post-stroke upper-limb therapy showed a 30% greater improvement in task accuracy and consistency compared to those following standard home exercise programs.

Market Dynamics:

Driver:

Growing elderly and post-stroke population

The rising global elderly population and increasing incidence of stroke-related disabilities are driving demand for home-based robot-assisted rehabilitation. These systems offer personalized therapy, improve mobility, and reduce dependence on clinical visits. With aging demographics and chronic conditions on the rise, robotic rehabilitation provides scalable, cost-effective solutions for long-term care. Governments and healthcare providers are investing in assistive technologies to support independent living and reduce hospital burden. This demographic shift is a major catalyst for market expansion.

Restraint:

High initial setup and maintenance costs

Despite clinical benefits, the high upfront cost of robotic rehabilitation systems limits adoption. Expenses include hardware, software integration, training, and ongoing maintenance. These costs are often not covered by insurance, making them inaccessible for many households. Additionally, technical complexity and the need for regular servicing add to operational burdens. Until cost-effective models and reimbursement frameworks are established, market penetration will remain constrained, especially in low-income and rural settings.

Opportunity:

Integration with telehealth rehabilitation programs

The integration of robotic rehabilitation systems with telehealth platforms presents a major growth opportunity. Remote monitoring, virtual therapy sessions, and AI-driven progress tracking enhance accessibility and continuity of care. Patients can receive guided exercises and feedback from clinicians without leaving home. This hybrid model supports post-operative recovery, chronic condition management, and stroke rehabilitation. As telehealth adoption accelerates, combining robotics with digital health infrastructure will unlock new service models and expand reach across underserved populations.

Threat:

Regulatory hurdles for robotic therapies

Robotic rehabilitation systems face complex regulatory pathways, especially for home use. Approval processes vary across regions and often require extensive clinical validation. Safety, efficacy, and data privacy standards must be met, delaying market entry and increasing compliance costs. Additionally, lack of harmonized guidelines for tele-rehabilitation and robotic interventions creates uncertainty for manufacturers. These regulatory challenges can slow innovation and limit cross-border scalability, posing a threat to rapid commercialization.

Covid-19 Impact:

The COVID-19 pandemic accelerated demand for remote rehabilitation solutions, including home-based robotic systems. Lockdowns and strained healthcare facilities highlighted the need for decentralized care. Patients recovering from stroke or surgery benefited from robotic therapy at home, reducing exposure risks. The crisis also spurred investment in telehealth and digital therapeutics, creating a favorable environment for robotic rehabilitation. Post-pandemic, hybrid care models combining in-person and remote therapy are gaining traction, reinforcing the long-term relevance of home-based robotic solutions.

The robot type segment is expected to be the largest during the forecast period

The robot type segment is expected to dominate the market due to its versatility and therapeutic precision. These systems include exoskeletons, end-effector robots, and wearable devices designed for upper and lower limb rehabilitation. Their ability to deliver repetitive, task-specific movements enhances motor recovery and patient engagement. As technology advances, robots are becoming more compact, user-friendly, and affordable. Clinical validation and growing patient acceptance further support segment leadership in home-based rehabilitation.

The motor function recovery segment is expected to have the highest CAGR during the forecast period

Motor function recovery is projected to register the highest CAGR, driven by increasing demand for post-stroke and orthopedic rehabilitation. Robotic systems offer targeted exercises that improve muscle strength, coordination, and neuroplasticity. AI algorithms personalize therapy based on patient progress, enhancing outcomes. As awareness of early intervention grows, motor recovery tools are being adopted for both acute and chronic conditions. The segment's scalability and measurable impact make it a key growth driver in robotic rehabilitation.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, supported by its aging population, rising stroke incidence, and expanding healthcare infrastructure. Countries like China, Japan, and South Korea are investing in assistive technologies and home-based care models. Government initiatives promoting digital health and rehabilitation access further boost adoption. Local manufacturers and startups are developing cost-effective robotic solutions tailored to regional needs. The region's demographic and policy landscape positions it as a leader in robotic rehabilitation.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR due to its advanced healthcare ecosystem, strong R&D capabilities, and early adoption of robotic therapies. The U.S. and Canada are integrating home-based rehabilitation into telehealth platforms, supported by favorable reimbursement policies. Leading companies and academic institutions are driving innovation in AI-enabled robotics. Growing awareness of post-stroke recovery and chronic care management fuels demand. Regulatory support and venture capital investment further accelerate market growth across the region.

Key players in the market

Some of the key players in Home-Based Robot Assisted Rehabilitation Market include Hocoma AG, ReWalk Robotics, Ekso Bionics, Myomo Inc., Motus Nova, Tyromotion, Ottobock, Cyberdyne Inc., Bionik Laboratories, Parker Hannifin, AlterG Inc., Fourier Intelligence, Kinova, Rehab-Robotics Co., MediTouch Ltd., Hyundai Motor Company, SuitX and Palladyne AI.

Key Developments:

In October 2025, Hocoma AG partnered with Palladyne AI to integrate adaptive AI into its Valedo home system. The upgrade personalizes spine therapy in real-time based on patient performance and progress metrics.

In September 2025, Ekso Bionics received FDA clearance for its new EksoIndy for Home, a lightweight, user-operated exoskeleton designed for unsupervised daily use by individuals with lower-limb paralysis or weakness.

In August 2025, Myomo Inc. launched a telehealth subscription service for its MyoPro orthosis. It provides remote therapy sessions and continuous data tracking for patients with arm paralysis due to stroke or SCI.

Types Covered:

  • Robot Type
  • Sensor Type
  • Deployment Mode

Therapy Types Covered:

  • Motor Function Recovery
  • Cognitive Rehabilitation
  • Post-Stroke Therapy
  • Orthopaedic Recovery

End Users Covered:

  • Elderly Patients
  • Post-Surgical Patients
  • Neurological Disorder Patients

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Home-Based Robot Assisted Rehabilitation Market, By Type

  • 5.1 Introduction
  • 5.2 Robot Type
    • 5.2.1 Exoskeleton Robots
    • 5.2.2 End-Effector Robots
    • 5.2.3 Wearable Robotics
    • 5.2.4 Therapy Companion Robots
  • 5.3 Sensor Type
    • 5.3.1 Motion Sensors
    • 5.3.2 Pressure Sensors
    • 5.3.3 EMG Sensors
    • 5.3.4 Temperature & Biofeedback Sensors
  • 5.4 Deployment Mode
    • 5.4.1 Standalone Home Units
    • 5.4.2 Cloud-Connected Systems
    • 5.4.3 Mobile App-Integrated Devices

6 Global Home-Based Robot Assisted Rehabilitation Market, By Therapy Type

  • 6.1 Introduction
  • 6.2 Motor Function Recovery
  • 6.3 Cognitive Rehabilitation
  • 6.4 Post-Stroke Therapy
  • 6.5 Orthopaedic Recovery

7 Global Home-Based Robot Assisted Rehabilitation Market, By End User

  • 7.1 Introduction
  • 7.2 Elderly Patients
  • 7.3 Post-Surgical Patients
  • 7.4 Neurological Disorder Patients

8 Global Home-Based Robot Assisted Rehabilitation Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Hocoma AG
  • 10.2 ReWalk Robotics
  • 10.3 Ekso Bionics
  • 10.4 Myomo Inc.
  • 10.5 Motus Nova
  • 10.6 Tyromotion
  • 10.7 Ottobock
  • 10.8 Cyberdyne Inc.
  • 10.9 Bionik Laboratories
  • 10.10 Parker Hannifin
  • 10.11 AlterG Inc.
  • 10.12 Fourier Intelligence
  • 10.13 Kinova
  • 10.14 Rehab-Robotics Co.
  • 10.15 MediTouch Ltd.
  • 10.16 Hyundai Motor Company
  • 10.17 SuitX
  • 10.18 Palladyne AI

List of Tables

  • Table 1 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Robot Type (2024-2032) ($MN)
  • Table 4 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Exoskeleton Robots (2024-2032) ($MN)
  • Table 5 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By End-Effector Robots (2024-2032) ($MN)
  • Table 6 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Wearable Robotics (2024-2032) ($MN)
  • Table 7 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Therapy Companion Robots (2024-2032) ($MN)
  • Table 8 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Sensor Type (2024-2032) ($MN)
  • Table 9 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Motion Sensors (2024-2032) ($MN)
  • Table 10 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Pressure Sensors (2024-2032) ($MN)
  • Table 11 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By EMG Sensors (2024-2032) ($MN)
  • Table 12 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Temperature & Biofeedback Sensors (2024-2032) ($MN)
  • Table 13 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 14 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Standalone Home Units (2024-2032) ($MN)
  • Table 15 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Cloud-Connected Systems (2024-2032) ($MN)
  • Table 16 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Mobile App-Integrated Devices (2024-2032) ($MN)
  • Table 17 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 18 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Motor Function Recovery (2024-2032) ($MN)
  • Table 19 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Cognitive Rehabilitation (2024-2032) ($MN)
  • Table 20 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Post-Stroke Therapy (2024-2032) ($MN)
  • Table 21 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Orthopaedic Recovery (2024-2032) ($MN)
  • Table 22 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Elderly Patients (2024-2032) ($MN)
  • Table 24 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Post-Surgical Patients (2024-2032) ($MN)
  • Table 25 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Neurological Disorder Patients (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.